Hepatitis E Virus Antibodies in Patients with Chronic Liver Disease

In the United States, the seroprevalence rate for hepatitis E virus (HEV) is ≈20%. This study examined HEV seroprevalence in persons with and without chronic liver disease. Our data indicate that HEV seropositivity is high in patients with chronic liver disease and that HEV seroprevalence increases...

Descripción completa

Detalles Bibliográficos
Autores principales: Atiq, Muslim, Shire, Norah J., Barrett, Anna, Rouster, Susan D., Sherman, Kenneth E., Shata, Mohamed T.
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2009
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681113/
https://www.ncbi.nlm.nih.gov/pubmed/19239770
http://dx.doi.org/10.3201/eid1503.080740
Descripción
Sumario:In the United States, the seroprevalence rate for hepatitis E virus (HEV) is ≈20%. This study examined HEV seroprevalence in persons with and without chronic liver disease. Our data indicate that HEV seropositivity is high in patients with chronic liver disease and that HEV seroprevalence increases significantly with age.

Ejemplares similares